Hints and tips:
...That saw the creation of Astellas Pharma, formed from a merger between Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical in 2005. Sankyo agreed to buy Daiichi Pharmaceutical the same year....
...The deal followed the creation of Astellas, through the merger of Fujisawa and Yamanouchi, and of Dai-ichi Sankyo, through the merger of those two companies, in 2005....
...In the pharmaceuticals sector, both Yamanouchi and Fujisawa rose after the two companies, set to merge next year, announced details of a medium-term business strategy....
...Yamanouchi fell 1 per cent to Y3,860 and Fujisawa was down 2 per cent at Y2,725....
...In the pharmaceuticals sector, both Yamanouchi and Fujisawa moved ahead after the two companies, set to merge next year, announced details of a medium-term business strategy....
International Edition